Font Size: a A A
Keyword [Essential thrombocythemia]
Result: 21 - 38 | Page: 2 of 2
21. The First Part Is The Study Of The Specific Changes And Mechanism Of The Bone Marrow Hematopoietic Microenvironment In Patients With Essential Thrombocythemia. The Second Part Is The Evaluation Of The Symptom Burden Of 173 Chinese Patients With Essential
22. The Expression And Clinical Significance Of Related Genes In Patients With Essential Thrombocythemia
23. The Clinical Research Of Myeloproliferative Diseases Treated By Huoxue Huayu Jiedu Recipe
24. Role Of PDGFRβ In Essential Thrombocythemia Induced By CALR Mutants
25. The Study On Compare And Prognostic In ET Patients With CALR And JAK2 Gene Mutation
26. Clinicla Characteristics And Risk Factors For 187 Chinese Patients With Essential Thrombocythemia
27. Analysis Of TCM Symptoms Of Essential Thrombocythemia And Preliminary Study Of Professor Yang Hongyong’s Law Of Herb Use For Essential Thrombocythemia
28. A Meta-analysis Of The Risk Of Thrombosis, Hemorrhage, And Disease Transformation In The Treatment Of Essential Thrombocythemia With Anagrelide
29. Environmental Etiology of Polycythemia Vera, Essential Thrombocythemia and Primary Myelofibrosis: A Case-Control Study in Northeast Pennsylvania
30. Coronary Artery Bypass Grafting In Patients With Essential Thrombocythemia
31. The Meta Analysis Of The Relationship Between JAK2 And CALR Mutations And Thrombosis In Essential Thrombocythemia
32. GATA2(rs2335052,rs78245253)in Patients With Acute Myeloid Leukemia And Whole-exome Sequencing Identifies Novel Candidate Predisposition Genes For Essential Thrombocythemia
33. The Study To Analysis The ET TCM Syndromes Based On IPSET-thrombosis Risk Stratification
34. Morphologic Characteristics Of Bone Marrow Histopathology Corresponding To Different Driver Gene Mutations (JAK2V617F,CALR) And Risk Stratification In ET And PMF Patients
35. Using Single Cell Technology To Analyze The Pathogenesis And Treatment Mechanism Of Essential Thrombocythemi
36. Serum Indirect Bilirubin Level Affects Platelet Count And Curative Effect In Patients With ET And PV
37. Construction Of Cell Models With Co-expression Of PDGFRβ And CALR Mutation And Study Of Their Effect On Promoting Cell Proliferation
38. Analysis Of Professor Hu Xiaomei’s Medication Regularity In The Treatment Of Essential Thrombocythemia Based On Data Mining
  <<First  <Prev  Next>  Last>>  Jump to